about
Tackling ALK in non-small cell lung cancer: the role of novel inhibitorsEngineered Resistant-Starch (ERS) Diet Shapes Colon Microbiota Profile in Parallel with the Retardation of Tumor Growth in In Vitro and In Vivo Pancreatic Cancer ModelsFhit loss in lung preneoplasia: relation to DNA damage response checkpoint activation.Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.A miRNA signature for defining aggressive phenotype and prognosis in gliomas.Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implications.Immunodetection of occult eosinophils in lung tissue biopsies may help predict survival in acute lung injury.Bronchial carcinoid tumors: nodal status and long-term survival after resection.Competitive allele-specific TaqMan PCR (Cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in Melanoma patients.Gene expression of muscular and neuronal pathways is cooperatively dysregulated in patients with idiopathic achalasia.BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients.Malignant solitary fibrous tumors of the pleura: retrospective review of a multicenter series.Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice.The role of molecular analyses in the diagnosis and treatment of non-small-cell lung carcinomas.Large cell carcinoma of the lung: a tumor in search of an author. A clinically oriented critical reappraisal.Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets.Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation.Endoscopic treatment of primary benign central airway tumors: Results from a large consecutive case series and decision making flow chart to address bronchoscopic excision.Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology.A malignant inflammatory myofibroblastic tumor of the hypopharynx harboring the 3a/b variants of the EML4-ALK fusion gene.ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.Increased frequency of bronchiolar histotypes in lung carcinomas associated with idiopathic pulmonary fibrosis.Treatment decision-making for advanced non-small cell lung cancer and differences among European countries: 1st AIOT-ETOP meeting.Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis.MEN1 gene mutation with parathyroid carcinoma: first report of a familial case.Pharmacokinetic drug evaluation of osimertinib for the treatment of non-small cell lung cancer.NRG1-ErbB Lost in Translation: A New Paradigm for Lung Cancer?The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR gene.ALK and NRG1 Fusions Coexist in a Patient with Signet Ring Cell Lung Adenocarcinoma.Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study.Diagnostic Performance of (18)F-Fluorodeoxyglucose in 162 Small Pulmonary Nodules Incidentally Detected in Subjects Without a History of Malignancy.A rare case of primary pulmonary epithelioid angiosarcoma detected by (18)F-FDG PET/CT.Primary neuroendocrine tumors of the thymus: a multicenter experience of 35 patients.Basic fibroblast growth factor and myointimal hyperplasia after experimental polytetrafluoroethylene arterial grafting.Dual role of VEGF in pretreated experimental ePTFE arterial grafts.Artifacts, Noise and Interference: Much Ado about Ultrasound.Human neutrophil peptides stimulate tumor necrosis factor-alpha release by alveolar macrophages from patients with sarcoidosis.Left Supraclavicular Swelling: Sclerosing Perineurioma.
P50
Q26740329-9942A80F-CBBE-40E6-B2F0-489ACAE17EDBQ33616599-180B1725-983E-41C7-88F9-AFD0FE345B5CQ33770934-3132DD70-0EDD-4932-81E0-C5BB39CBFD60Q34234101-3443918D-5CDC-4340-BC7A-5A4538688AB5Q34287223-4F3B35B0-1437-4B83-BF9F-0240E2D7C2E2Q34359601-329445A0-1236-4D49-BF9C-B95A6BB2287AQ35222596-5D48F13A-459C-4083-A2E1-AF9954F0E90CQ35757382-5C49C47F-6B30-4328-A763-5AEB32789349Q36392912-661C203D-7C7C-4083-9746-785F7CD8316CQ37166742-A5AF8AD6-28C8-4564-B1CF-A5FF617FA122Q37216950-8414A677-3040-4D8F-9A08-F2CD04816992Q37706890-C04049E1-CBCB-459C-BC96-63188961433CQ37721631-6AD581E2-4403-429B-9A45-B16894DB0420Q38052422-B6F28C00-4210-4959-99F2-0FD41E0FCDFAQ38112386-34A65C4E-543B-4D2F-8182-E0CDEEA770BEQ38171602-70F215DB-5F36-469D-BE80-AE6AABC78406Q38332362-91A80C55-B67C-4E94-928B-D6B2C83678ACQ39617870-1E703EEA-0FAC-433C-8261-4BC8FD698D10Q40298907-88A50E70-BAE6-4F5F-9CF6-2FDCE0B9E3FDQ40584823-EE283AD2-7501-430E-B563-606F9AD1294EQ42256127-86212450-0761-40DC-90E4-AC55C839416FQ42316364-EE49B1FC-6A1C-478E-9538-F63DABAE7CE7Q42435605-4D982085-6F8D-4779-998A-67B7A2121664Q42510392-B2A6A16E-5018-4BAF-86AA-04C1F45F605DQ43423171-3DE36459-AC22-4CA3-8E42-F4604E2A7BCBQ44280426-FF048AC4-CD17-4E7D-9A24-1D7FB5C12FC5Q47135439-1D91BCE8-3652-4E44-893E-C95ABCE677EFQ47450308-69C351E4-EB3D-432A-BE99-ABCBA324759CQ47812525-0D8A69EA-C65A-4FD7-9BB7-1145F711F3C5Q47923518-B35953B0-477E-4640-BE33-2BDDC3F3AE59Q49916508-D6FAED2D-9B75-4158-91CE-60CE43A389F6Q50496257-1B7342B8-23D7-4D1E-884D-BB71493E6AE4Q50724905-3E1638E3-E4DC-4E6B-94B9-9E2178EC4531Q51244989-B6B9150F-EA9F-419E-B68F-9D0443E2C7A9Q51337093-379C42A9-93DE-421E-A19A-0356ABE2FC1AQ51440224-0CB07305-8394-47C4-B24D-917C1A4F56F3Q51451283-3EE50C20-FB77-4725-A8D1-9F2D4204EAD9Q51645335-AF3D1778-4A49-4EE4-8BD9-26A94A9EFA71Q51833659-92EA3345-198F-4156-B7A4-14796BCB7133Q52659372-DAE52686-8835-4195-BF56-325612BA1529
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Paolo Graziano
@ast
Paolo Graziano
@en
Paolo Graziano
@es
Paolo Graziano
@nl
Paolo Graziano
@sl
type
label
Paolo Graziano
@ast
Paolo Graziano
@en
Paolo Graziano
@es
Paolo Graziano
@nl
Paolo Graziano
@sl
prefLabel
Paolo Graziano
@ast
Paolo Graziano
@en
Paolo Graziano
@es
Paolo Graziano
@nl
Paolo Graziano
@sl
P106
P1153
6603997187
P21
P31
P496
0000-0001-7066-7896